| Drug Name | Volibris (Ambrisentan) |
|---|---|
| Drug Class |
Anti-hypertension
|
| Risk minimization type |
Healthcare provider guide
patient guide
|
| Specialty (Theraputic area) |
Cardiology
|
| Risk |
Risk of foetal exposure and adverse foetal outcomes. |
| patient guide |
|
| Health care provider guide |
|